Molecular Characterization of δβ Thalassemia/Hereditary Persistence of Fetal Hemoglobin and Its Correlation With Clinical and Hematological Profile; a Single Center Study in North India.

Ahead of Print

Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 101300213 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1751-553X (Electronic) Linking ISSN: 17515521 NLM ISO Abbreviation: Int J Lab Hematol Subsets: MEDLINE

Original Publication: Oxford : Blackwell Scientific Publications, c2007-

Background: δβ-thalassemia/HPFH is an uncommon hemoglobinopathy characterized by decreased or the total absence of production of δ- and β-globin and increased HbF levels. Both these disorders have variable genotype and phenotype, but significant overlap in the clinical and laboratory findings. Given the lack of literature in this regard, the study aimed to estimate the prevalence of the disease and evaluate its clinical, hematological, and molecular profile in India.
Material and Methods: This was a retrospective study where all samples with HbF level ≥ 5% and suspected to be δβ-thalassemia/HPFH, based on the HPLC, were included in the study over 3.5 years. The demographic and clinical details were retrieved from the electronic medical records. Gap-PCR was carried out to characterize the molecular defect for the HbF determinant, while amplification refractory mutation system (ARMS-PCR) was carried out for β-thalassemia genoyping. Clinical and laboratory parameters of heterozygous and homozygous/compound heterozygous δβ thalassemia deletions were compared.
Results: A total of 65 individuals (0.8%) were diagnosed with δβ-thalassemia/HPFH; these included 45 (69%) patients in the heterozygous group and 20 (31%) cases in the homozygous/compound heterozygous subgroup. While all the carrier states were asymptomatic, 80% of the patients in the homozygous/compound heterozygous state were symptomatic with a thalassemia intermedia-like profile. The median Hb levels were 12.3 g/dL (range -9.5-18.2) and 8.0 g/dL (range 3.8-15.1) respectively. Molecular profiling identified heterozygous Asian Indian inversion deletion ^G γ( ^A γδβ) ⁰ mutation in 50% of cases, heterozygous HPFH-3 (Indian HPFH, 48.5 kb deletion) in 14% cases, and homozygous ^G γ( ^A γδβ) ⁰ -thalassemia in 21% cases. Compound heterozygous HPFH-3/ ^G γ( ^A γδβ) ⁰ mutation with β-thalassemia was observed in 8.9% and 3.5%, respectively. In one case, the HbF determinant could not be identified. Heterozygous (HBB:c. 92+5G>C), was the most frequent co-inherited β-thalassemia mutation in the compound heterozygous patients.
Conclusion: The study highlights that high HbF determinants, like δβ thalassemia and HPFH, are relatively more frequent in the Indian subcontinent, and their co-inheritance with β-thalassemia results in a moderately severe disease. Accurate identification of molecular defects is important for prenatal diagnosis and genetic counseling.
(© 2024 John Wiley & Sons Ltd.)

S. L. Thein, W. G. Wood, M. H. Steinberg, B. G. Forget, D. R. Higgs, and D. J. Weatherall, “The Molecular Basis of β Thalassemia, δβ Thalassemia, and Hereditary Persistence of Fetal Hemoglobin,” in Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management (Cambridge: Cambridge University Press, 2009), 323–356.
B. G. Forget, “Molecular Basis of Hereditary Persistence of Fetal Hemoglobin,” Annals of the New York Academy of Sciences 30, no. 850 (1998): 38–44, https://doi.org/10.1111/j.1749‐6632.1998.tb10460.x.
A. Amato, M. P. Cappabianca, M. Perri, et al., “Interpreting Elevated Fetal Hemoglobin in Pathology and Health at the Basic Laboratory Level: New and Known γ‐ Gene Mutations Associated With Hereditary Persistence of Fetal Hemoglobin,” International Journal of Laboratory Hematology 36, no. 1 (2014): 13–19, https://doi.org/10.1111/ijlh.12094.
S. Fucharoen, Y. Pengjam, S. Surapot, G. Fucharoen, and K. Sanchaisuriya, “Molecular and Hematological Characterization of HPFH‐6/Indian Deletion‐Inversion Gγ(Aγδβ)0‐Thalassemia and Gγ(Aγδβ)0‐Thalassemia/Hb E in Thai Patients,” American Journal of Hematology 68 (2002): 109–113, https://doi.org/10.1002/ajh.10202.
F. Jiang, L. Zuo, D. Li, et al., “Molecular Epidemiology and Hematologic Characterization of δβ‐Thalassemia and Hereditary Persistence of Fetal Hemoglobin in 125,661 Families of Greater Guangzhou Area, the Metropolis of Southern China,” BMC Medical Genetics 21, no. 1 (2020): 43, https://doi.org/10.1186/s12881‐020‐0981‐x.
T. Bilgen, Ö. Altıok Clark, Z. Öztürk, M. A. Yeşilipek, and İ. Keser, “Gap‐PCR Screening for Common Large Deletional Mutations of β‐Globin Gene Cluster Revealed a Higher Prevalence of the Turkish Inversion/Deletion (δβ)0 Mutation in Antalya,” Turkish Journal of Haematology 33, no. 2 (2016): 107–111, https://doi.org/10.4274/tjh.2014.0242.
D. Velasco‐Rodríguez, J. M. Alonso‐Domínguez, F. A. González‐Fernández, et al., “δβ‐Thalassemia Trait: How Can We Discriminate It From β‐Thalassemia Trait and Iron Deficiency Anemia?,” American Journal of Clinical Pathology 142, no. 4 (2014): 567–573, https://doi.org/10.1309/AJCPPBQ8UB1WHXTS.
A. Nadkarni, M. Wadia, A. Gorakshakar, R. Kiyama, R. B. Colah, and D. Mohanty, “Molecular Characterization of Delta Beta‐Thalassemia and Hereditary Persistence of Fetal Hemoglobin in the Indian Population,” Hemoglobin 32, no. 5 (2008): 425–433, https://doi.org/10.1080/03630260802341687.
T. Mayuranathan, J. Rayabaram, R. Das, et al., “Identification of Rare and Novel Deletions That Cause (δβ)0‐Thalassaemia and Hereditary Persistence of Foetal Haemoglobin in Indian Population,” European Journal of Haematology 92, no. 6 (2014): 514–520, https://doi.org/10.1111/ejh.12276.
S. Pandey, S. Pandey, R. Ranjan, R. Mishra, M. Sharma, and R. Saxena, “Phenotypic Heterogeneity of Asian Indian Inversion Deletions Gγ(Aγδβ)0 Breakpoint a and Breakpoint B,” Indian Journal of Clinical Biochemistry 28, no. 1 (2013): 98–101, https://doi.org/10.1007/s12291‐012‐0232‐9.
P. Hariharan, P. Kishnani, P. Sawant, et al., “Genotypic‐Phenotypic Heterogeneity of δβ‐Thalassemia and Hereditary Persistence of Fetal Hemoglobin (HPFH) in India,” Annals of Hematology 99, no. 7 (2020): 1475–1483, https://doi.org/10.1007/s00277‐020‐04081‐8.
J. M. Khunger, M. Gupta, R. Singh, R. Kapoor, and H. R. Pandey, “Haematological Characterisation and Molecular Basis of Asian Indian Inversion Deletions Delta Beta Thalassemia: A Case Report,” Journal of Clinical and Diagnostic Research 8, no. 9 (2014): FD01‐2, https://doi.org/10.7860/JCDR/2014/8362.4776.
S. Dehury, P. Purohit, S. Meher, K. Das, and S. Patel, “Compound Heterozygous State of β‐Thalassemia With IVS1‐5 (G→C) Mutation and Indian Deletion‐Inversion Gγ(Aγδβ)0‐Thalassemia in Eastern India,” Revista Brasileira de Hematologia e Hemoterapia 37, no. 3 (2015): 202–206, https://doi.org/10.1016/j.bjhh.2014.12.002.
H. Lad, P. Ghanghoria, R. Yadav, P. Patel, A. Gwal, and R. Shanmugam, “A Compound Heterozygous Asian Indian Inversion Deletion Gγ(Aγδβ)0 With β‐Thalassemia in Central India: A Case Report,” Indian Journal of Hematology and Blood Transfusion 34, no. 1 (2018): 185–187, https://doi.org/10.1007/s12288‐017‐0806‐z.
S. Waghela, S. Sharma, N. Shah, H. Uchil, and R. Ghildiyal, “Varied Clinical Presentation of Compound Heterozygous Thalassemia With Delta Beta or Hereditary Persistence of Foetal Hemoglobin,” Pediatric Hematology and Oncology 8, no. 1 (2023): 31–33, https://doi.org/10.1016/j.phoj.2023.01.002.
J. E. Craig, R. A. Barnetson, J. Prior, J. L. Raven, and S. L. Thein, “Rapid Detection of Deletions Causing Delta Beta Thalassemia and Hereditary Persistence of Fetal Hemoglobin by Enzymatic Amplification,” Blood 83, no. 6 (1994): 1673–1682.
K. K. Mishra, P. Patel, D. S. Bhukhanvala, A. Shah, and K. Ghosh, “A Multiplex ARMS PCR Approach to Detection of Common β‐Globin Gene Mutations,” Analytical Biochemistry 537 (2017): 93–98, https://doi.org/10.1016/j.ab.2017.06.014.
M. Chen, M. Zhang, L. Chen, et al., “Genetic Research and Clinical Analysis of β‐Globin Gene Cluster Deletions in the Chinese Population of Fujian Province: A 14‐Year Single‐Center Experience,” Journal of Clinical Laboratory Analysis 36, no. 2 (2022): e24181, https://doi.org/10.1002/jcla.24181.
M. Bravo‐Urquiola, A. Arends, G. Gómez, et al., “Molecular Spectrum of β‐Thalassemia Mutations in the Admixed Venezuelan Population, and Their Linkage to β‐Globin Gene Haplotypes,” Hemoglobin 36, no. 3 (2012): 209–218, https://doi.org/10.3109/03630269.2012.674997.
J. S. Wainscoat, J. M. Old, W. G. Wood, R. J. Trent, and D. J. Weatherall, “Characterization of an Indian (Delta Beta)0 Thalassaemia,” British Journal of Haematology 58, no. 2 (1984): 353–360, https://doi.org/10.1111/j.1365‐2141.1984.tb06094.x.
U. Bhardwaj and E. R. McCabe, “Multiplex‐PCR Assay for the Deletions Causing Hereditary Persistence of Fetal Hemoglobin,” Molecular Diagnosis 9, no. 3 (2005): 151–156.
J. Tritipsombut, M. Phylipsen, V. Viprakasit, et al., “A Single‐Tube Multiplex Gap‐Polymerase Chain Reaction for the Detection of Eight β‐Globin Gene Cluster Deletions Common in Southeast Asia,” Hemoglobin 36, no. 6 (2012): 571–580, https://doi.org/10.3109/03630269.2012.747441.
J. Cui, M. Azimi, C. Baysdorfer, E. P. Vichinsky, and C. C. Hoppe, “Application of Multiplex Ligation‐Dependent Probe Amplification to Screen for β‐Globin Cluster Deletions: Detection of Two Novel Deletions in a Multiethnic Population,” Hemoglobin 37, no. 3 (2013): 241–256, https://doi.org/10.3109/03630269.2013.782461.

EMDR/SG/13/2023-4199 ICMR

Keywords: India; delta‐beta thalassemia; hereditary persistence of fetal hemoglobin (HPFH); molecular

Date Created: 20241228 Latest Revision: 20241228

20241228

10.1111/ijlh.14419

39731309